199TiP A first-in-human phase I study of IPH5301, an anti-CD73 monoclonal antibody, alone or in combination with chemotherapy and trastuzumab, in patients with advanced solid tumors (CHANCES)

التفاصيل البيبلوغرافية
العنوان:	199TiP A first-in-human phase I study of IPH5301, an anti-CD73 monoclonal antibody, alone or in combination with chemotherapy and trastuzumab, in patients with advanced solid tumors (CHANCES)
المؤلفون:	Gonçalves, A., Vicier, C., Guerin, M., Pignon, J., Chanez, B., Provansal Gross, M., Penel, N., Kotecki, N., Marie, D.B., Boyer Chammard, A., Paturel, C.L., André, P., Pakradouni, J., Boher, J.M., Awada, F.
المصدر:	In Immuno-Oncology and Technology December 2022 16 Supplement 1
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	25900188
DOI:	10.1016/j.iotech.2022.100348